Member access

4-Traders Homepage  >  Shares  >  Nasdaq  >  Vertex Pharmaceuticals Incorporated    VRTX   US92532F1003

 SummaryQuotesChart AnalysisNewsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
10/20/2014 10/21/2014 10/22/2014 10/23/2014 10/24/2014 Date
104.77(c) 108.16(c) 106.17(c) 108.09(c) 109.91(c) Last
1 178 616 1 897 317 1 539 994 1 261 219 936 361 Volume
+2.36% +3.24% -1.84% +1.81% +1.68% Change
More quotes
Company
Vertex Pharmaceuticals, Inc. is engaged in the business of discovering, developing, manufacturing and commercializing small molecule drugs.The company's research focuses on cystic fibrosis; infectious diseases, including viral infections, such as influenza, and bacterial infections; autoimmune... 
Sector
Pharmaceuticals
Calendar
02/05Earnings Release
Surperformance© rating of Vertex Pharmaceuticals Inc
Trading Rating : Investor Rating :
More about the company
Chart VERTEX PHARMACEUTICALS INC
Duration : Period :
Vertex Pharmaceuticals Inc Technical Analysis Chart | VRTX | US92532F1003 | 4-Traders
Full-screen chart
Financials ($)
Sales 2014 552 M
EBIT 2014 -669 M
Net income 2014 -682 M
Finance 2014 449 M
Yield 2014 -
Sales 2015 1 376 M
EBIT 2015 149 M
Net income 2015 14,6 M
Finance 2015 836 M
Yield 2015 -
PER 2014 -
PER 2015 1 590,59
EV / Sales 2014 46,6x
EV / Sales 2015 18,4x
Capitalization 26 168 M
More Financials
Latest news on VERTEX PHARMACEUTICALS INC
3d ago VERTEX PHARMACEUTICALS : to Announce Third Quarter 2014 Financial Results on Oct..
3d agoDJU.S. HOT STOCKS : Hot Stocks to Watch
4d ago VERTEX PHARMACEUTICALS : FDA Advisory Committee Recommends Approval of KALYDECO®..
5d ago VERTEX PHARMACEUTICALS : Health and Human Services Department (HHS); Food and Dr..
10/16 AbbVie board ditches planned $55 billion Shire acquisition
10/15 VERTEX PHARMACEUTICALS : Patent Issued for Modulators of ATP-Binding Cassette Tr..
10/15 VERTEX PHARMACEUTICALS : Patent Issued for Multiwell Assay Apparatus and Method ..
10/15 VERTEX PHARMACEUTICALS : Patent Issued for Thiophene-Carboxamides Useful as Inhi..
10/14 VERTEX PHARMACEUTICALS : to Announce Third Quarter 2014 Financial Results on Oct..
10/13 Wall St. drops in late selloff; worst three days for S&P 500 since 2011
10/13 NASDAQ 100 MOVERS : Tsla, vrtx
10/13 VERTEX PHARMACEUTICALS : Health and Human Services Department (HHS); Food and Dr..
More news


Comments 
Advertisement
Technical analysis trends
Short TermMid-TermLong Term
TrendsNeutralBullishBullish
Technical analysis
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions
Dynamic quotes  
ON
| OFF